Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aurontx.com

Founded Year

2018

Stage

Series A | Alive

Total Raised

$61.41M

Last Raised

$48M | 2 mos ago

About Auron Therapeutics

Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to the transformation of malignant cells into more normal functioning cells. Auron Therapeutics was founded in 2018 and is based in Wellesley, Massachusetts.

Auron Therapeutics Headquarters Location

7 Norwich Road

Wellesley, Massachusetts, 02481,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Auron Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Auron Therapeutics is included in 2 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Auron Therapeutics News

Auron Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Auron Therapeutics Rank

  • When was Auron Therapeutics founded?

    Auron Therapeutics was founded in 2018.

  • Where is Auron Therapeutics's headquarters?

    Auron Therapeutics's headquarters is located at 7 Norwich Road, Wellesley.

  • What is Auron Therapeutics's latest funding round?

    Auron Therapeutics's latest funding round is Series A.

  • How much did Auron Therapeutics raise?

    Auron Therapeutics raised a total of $61.41M.

  • Who are the investors of Auron Therapeutics?

    Investors of Auron Therapeutics include BrightEdge, Arkin Bioventures, Qiming Venture Partners, Polaris Partners, Casdin Capital and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.